ROMOSOZUMAB AS A TREATMENT AFTER BISPHOSPHONATE OR FOR OSTEOPOROSIS WITH T-SCORE≦-2.5 IN CLINICAL PRACTICE

Authors
Category Primary study
JournalAnnals of the Rheumatic Diseases
Year 2023
This article has no abstract
Epistemonikos ID: 7b984e5889f73ff43f14d6d3d06713795d7c88ca
First added on: Feb 16, 2025